Abstract
This study sought to ascertain the prevalence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) among a sample of 465 patients with Long COVID. The participants completed three questionnaires: (1) a new questionnaire measuring both the frequency and severity of 38 common symptoms of COVID and Long COVID, (2) a validated short form questionnaire assessing ME/CFS, and (3) a validated questionnaire measuring post-exertional malaise. The population was predominantly white, female, and living in North America. The mean duration since the onset of COVID-19 symptoms was 70.5 weeks. Among the 465 participants, 58% met a ME/CFS case definition. Of respondents who reported that they had ME/CFS only 71% met criteria for ME/CFS and of those who did not report they had ME/CFS, 40% nevertheless did meet criteria for the disease: both over-diagnosis and under-diagnosis were evident on self-report. This study supports prior findings that ME/CFS occurs with high prevalence among those who have persistent COVID-19 symptoms.
Funder
National Institute of Neurological Disorders and Stroke
Reference36 articles.
1. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review;Chen;J. Infect. Dis.,2022
2. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: A longitudinal cohort study;Huang;Lancet Respir. Med.,2022
3. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?;Komaroff;Front. Med.,2021
4. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis;Perelman;Sci. Rep.,2021
5. Center for Disease Control and Prevention (2022, October 02). Long COVID. Center for Disease Control and Prevention, Available online: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献